New report reveals how groundbreaking research at the Campus is delivering major gains for UK economic growth and job creation
Cambridge, UK, 28th November 2024: A new independent report evaluating the economic and scientific impact of the Babraham Research Campus has revealed significant contributions not only to the UK and global life sciences sector, but to the local Cambridge and wider UK economy.
The London BioScience Innovation Centre (LBIC) is seeking a Part-Time Receptionist to ensure great service to its clients. A subsidiary of the RVC, LBIC provides laboratories, office space and related services to life science companies.
The Receptionist provides front-of-house support to all LBIC client companies, including management of deliveries, post, phone calls, meeting rooms, visitors and related administrative tasks.
This role is for three days per week, 8.30am-5.30pm.
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
London, November 26, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Entia and is pleased to announce the placement of Timothy Broke-Smith as Senior Vice President of Partnerships.
Europa Biosite is pleased to announce the acquisition of AMSBIO, a premier supplier of life science products and services, with expertise in the areas of biospecimens, stem cell research, 3D cell culture, glycobiology, and molecular biology. Headquartered in Oxford, UK, and with offices in both the USA and the Netherlands, AMSBIO serves life science researchers across Europe and throughout North America.
A new industry briefing note developed by Pioneer Group in collaboration with the UK chemicals sector community highlights the urgent need for the sector to transition to a more sustainable, circular economy.
The paper, developed at a ‘Pioneer Presents’ workshop held at the Wilton Centre, Tees Valley, earlier this year, outlines the environmental challenges associated with the sector’s current reliance on fossil resources, the potential of sustainable carbon feedstocks, and the significant actions required to transform the UK chemicals industry.
Established in 2000, LBIC provides a focus for life science activity in London, offering laboratory and office facilities as well as a virtual service to meet the needs of a wide range of organisations, from micro businesses to multi-national corporations. LBIC is owned and operated by the prestigious Royal Veterinary College (RVC), the UK’s largest and longest-established veterinary institution. LBIC will soon expand into an additional building to offer further opportunities for companies.
London, November 21, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Solu Therapeutics (Solu) and is pleased to announce the placement of Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO).
Solu Therapeutics is a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas.
Significant CRO C-suite experience expected to drive growth and commercial expansion into global markets